Belite Bio (Belite Bio) Accumulated other comprehensive income (loss) : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Belite Bio's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $0.00 Mil.

Belite Bio's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($-0.37 Mil) but then increased from Dec. 2023 ($-0.37 Mil) to Mar. 2024 ($0.00 Mil).

Belite Bio's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-0.20 Mil) to Dec. 2022 ($-0.39 Mil) but then increased from Dec. 2022 ($-0.39 Mil) to Dec. 2023 ($-0.37 Mil).

Belite Bio Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Belite Bio's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Accumulated other comprehensive income (loss) Chart

Belite Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

-0.04

-0.20

-0.39

-0.37

Belite Bio Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial							-	-	-	-0.37	-

Belite Bio Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Belite Bio Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Belite Bio's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Belite Bio (Belite Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

D01:Germany

Address

12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130

Website

https://www.belitebio.com

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.